A Phase I, Open Label, Randomized, 2-Panel, 2-Way Crossover Trial to Investigate the Pharmacokinetic Interaction Between Etravirine or TMC278 and Telaprevir at Steady-State in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 May 2014
At a glance
- Drugs Rilpivirine (Primary) ; Etravirine; Telaprevir
- Indications Hepatitis C; HIV infections
- Focus Pharmacogenomic; Pharmacokinetics
- 07 Jun 2017 Biomarkers information updated
- 23 Nov 2011 Actual end date Sep 2011 added as reported by ClinicalTrials.gov.
- 23 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.